4.5 Article

T1-based sensing of mammographic density using single-sided portable NMR

Journal

MAGNETIC RESONANCE IN MEDICINE
Volume 80, Issue 3, Pages 1243-1251

Publisher

WILEY
DOI: 10.1002/mrm.27098

Keywords

breast cancer risk; longitudinal spin-relaxation time constant (T-1); mammographic density; mammography; portable single-sided NMR

Funding

  1. Princess Alexandra Research Foundation (ALH Breast Cancer Project Grant)
  2. Translational Research Institute (SPORE Grant)
  3. Australian Government

Ask authors/readers for more resources

PurposeA single-sided NMR instrument was used to investigate the ability of the T-1 relaxation constant to distinguish between regions of low and high mammographic density in human breast tissue. MethodsMeasurements were performed on 5 breast slices obtained from 3 women undergoing breast reduction surgery or prophylactic mastectomy. ResultsT(1) values measured in regions of high mammographic density in both the full breast slices (T-1=17030 ms) and excised regions (T-1=160 +/- 30 ms) were found to be significantly different (P<.001) from those measured in regions of low mammographic density, in which T-1=120 +/- 10 ms was observed both in full slices and excised regions. There was no statistically significant difference between the T-1 values measured in the full breast slices and those measured in the excised regions. ConclusionThe findings suggest that portable NMR may provide a low-cost means of assessing mammographic density in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Anatomy & Morphology

Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications

Mohit Kumar Jolly, Ryan J. Murphy, Sugandha Bhatia, Holly J. Whitfield, Andrew Redfern, Melissa J. Davis, Erik W. Thompson

Summary: The epithelial-mesenchymal (E/M) hybrid state plays a significant role in cancer progression, facilitated by epithelial mesenchymal plasticity (EMP). Modeling and validation studies have shown the stabilised E/M hybrid states across the spectrum of EMP, along with computational approaches for characterising EMP phenotypes.

CELLS TISSUES ORGANS (2022)

Article Hematology

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL

Piers Blombery, Thomas E. Lew, Michael A. Dengler, Ella R. Thompson, Victor S. Lin, Xiangting Chen, Tamia Nguyen, Ashish Panigrahi, Sasanka M. Handunnetti, Dennis A. Carney, David A. Westerman, Constantine S. Tam, Jerry M. Adams, Andrew H. Wei, David C. S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson

Summary: The BCL2 inhibitor venetoclax has therapeutic roles in CLL and AML and can lead to clinical and molecular abnormalities in the myeloid compartment. Mutations in the apoptosis effector BAX may result in resistance to venetoclax. Co-occurrence of BAX mutations with DNMT3A or ASXL1 mutations was observed in clonal hematopoiesis.

BLOOD (2022)

Editorial Material Anatomy & Morphology

Special Issue: Epithelial-Mesenchymal Transition 2020

Erik W. W. Thompson, Guojun Sheng

CELLS TISSUES ORGANS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping

Ashley Wilton Stewart, Simon Daniel Robinson, Kieran O'Brien, Jin Jin, Georg Widhalm, Gilbert Hangel, Angela Walls, Jonathan Goodwin, Korbinian Eckstein, Monique Tourell, Catherine Morgan, Aswin Narayanan, Markus Barth, Steffen Bollmann

Summary: A robust masking technique and reconstruction procedure were developed to automatically separate reliable from less reliable phase regions, operating on two-pass reconstruction to extract more information and suppress streaking artifacts, leading to significant artifact and error reductions, greater anatomical detail, and minimal parameter tuning across a range of acquisitions.

MAGNETIC RESONANCE IN MEDICINE (2022)

Article Biology

Sensing mammographic density using single-sided portable Nuclear Magnetic Resonance

Maher Alqurashi, Konstantin Momot, Ali Aamry, H. Almohammed, Hussin Aamri, Yehia H. Johary, Fouad A. Abolaban, Abdelmoneim Sulieman

Summary: This research paper introduces a quantitative approach to sensing mammographic density using single-sided portable Nuclear Magnetic Resonance (NMR). The study validates the effectiveness of three main NMR techniques and finds strong correlations and agreements between them in measuring mammographic density.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2022)

Article Neurosciences

Modelling the depth-dependent VASO and BOLD responses in human primary visual cortex

Atena Akbari, Saskia Bollmann, Tonima S. Ali, Markus Barth

Summary: Functional magnetic resonance imaging (fMRI) using blood-oxygenation-level-dependent (BOLD) contrast is a widely used noninvasive method for studying human brain function. However, spatial signal specificity in depth-dependent fMRI can be degraded due to signal leakage. VAscular-Space-Occupancy (VASO) contrast, which measures cerebral blood volume, has shown higher spatial specificity compared to BOLD. In this study, a cortical vascular model was used to predict layer-specific BOLD and VASO responses in the human primary visual cortex, and the model's predictions were compared with experimental results. The results confirmed that VASO is less affected by large vessel effects compared to BOLD.

HUMAN BRAIN MAPPING (2023)

Article Biochemistry & Molecular Biology

Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation

Ferran Nadal-Bufi, Lai Y. Chan, Hadi H. Mohammad, Jody M. Mason, Carlos Salomon, Andrew Lai, Erik W. Thompson, David J. Craik, Quentin Kaas, Sonia T. Henriques

Summary: This study reports the first peptide-based LDH5 inhibitor that can modulate cancer metabolism and kill glycolytic cancer cells. The study demonstrates the potential of using peptides as inhibitors of intracellular protein-protein interactions relevant for cancer pathways and shows that active peptides can be rationally designed to improve their cell permeation.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Engineering, Biomedical

Exploring the Potential of PEG-Heparin Hydrogels to Support Long-Term Ex Vivo Culture of Patient-Derived Breast Explant Tissues

Maria K. Koch, Akhilandeshwari Ravichandran, Berline Murekatete, Julien Clegg, Mary Teresa Joseph, Madison Hampson, Mitchell Jenkinson, Hannah S. Bauer, Cameron Snell, Cheng Liu, Madeline Gough, Erik W. Thompson, Carsten Werner, Dietmar W. Hutmacher, Larisa M. Haupt, Laura J. Bray

Summary: Breast cancer is a complex and dynamic disease, and the leading cause of cancer-related death in women worldwide. Evaluation of breast cancer heterogeneity is crucial for identifying new treatment strategies. A new ex vivo culture model using poly(ethylene glycol) and maleimide-functionalized heparin hydrogels is presented, which allows for the culture of human mammary tissue for up to 3 weeks and maintains the tissue structure and phenotype. The model is relevant for testing therapeutic interventions and highlights the importance of donor-to-donor variability and tissue heterogeneity.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Pharmacology & Pharmacy

GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids

Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark N. Adams, Laura J. Bray, Laura Croft, Erik W. Thompson, Thomas Kryza, Christoph Meinert

Summary: 3D organoid model technologies and tunable hydrogel matrices provide innovative tools for cancer precision medicine, specifically for drug testing in breast cancer by mimicking key characteristics of the disease's extracellular matrix.

PHARMACEUTICS (2023)

Review Biochemistry & Molecular Biology

Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers

Xiaofeng Dai, Erik W. Thompson, Kostya (Ken) Ostrikov

Summary: Cancer cells are more susceptible to abnormal redox fluctuations due to their imbalanced antioxidant system and cell surface receptors can sense stress and trigger intracellular signals. Targeting cell receptors can sensitize cancer cells to specific drugs, but cell receptor mutations are often associated with drug resistance. Therefore, exploring effective therapeutics targeting diverse cell receptors is significant for combating aggressive cancers. Cold atmospheric plasma (CAP) is considered a promising redox modulation medium and highly selective anti-cancer treatment, offering dynamically changing receptor targets and reduced drug resistance against aggressive cancers.

BIOMOLECULES (2022)

Article Chemistry, Multidisciplinary

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer

Charlene Waryah, Joseph Cursons, Momeneh Foroutan, Christian Pflueger, Edina Wang, Ramyar Molania, Anabel Sorolla, Christopher Wallis, Colette Moses, Irina Glas, Leandro Magalhaes, Erik W. Thompson, Liam G. Fearnley, Christine L. Chaffer, Melissa Davis, Anthony T. Papenfuss, Andrew Redfern, Ryan Lister, Manel Esteller, Pilar Blancafort

Summary: This work successfully silenced ZEB1 in triple negative breast cancer (TNBC) models through CRISPR/dCas9-mediated epigenetic editing, leading to significant tumor inhibition and the discovery of ZEB1-dependent-signature genes. Epigenetic changes, including reactivation and enhanced chromatin accessibility, were observed in cell adhesion loci, indicating a shift towards a more epithelial state. Silencing of ZEB1 also induced heterochromatin expansion, DNA methylation changes, and chromatin modifications in the ZEB1 promoter. This study demonstrated the potential of epigenome-engineering approaches and customizable precision molecular oncology for targeting poor outcome breast cancers.

ADVANCED SCIENCE (2023)

Review Oncology

Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs

Charlene Waryah, Eric Alves, Roberta Mazzieri, Riccardo Dolcetti, Erik W. Thompson, Andrew Redfern, Pilar Blancafort

Summary: The article reviews the importance of epithelial plasticity in cancer development, discussing the role of epithelial-to-mesenchymal transition (EMT) in cancer metastasis, drug resistance, etc., and introduces the related regulatory factors and treatment strategies.

CANCERS (2023)

Article Biotechnology & Applied Microbiology

Plasma-activated medium triggers immunomodulation and autophagic activity for periodontal regeneration

Shengfang Wang, Peiyu Wang, Rik Thompson, Kostya Ostrikov (Ken), Yin Xiao, Yinghong Zhou

Summary: PAM can reduce the inflammatory response of macrophages by activating autophagy and promote the regeneration of periodontal tissues, making it an ideal choice for periodontitis treatment.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Article Oncology

Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours

Sugandha Bhatia, Jennifer H. Gunter, Joshua Burgess, Mark N. Adams, Kenneth O'Byrne, Erik W. Thompson, Pascal H. G. Duijf

Summary: Epithelial-mesenchymal plasticity (EMP) is a characteristic of cancer that promotes invasion, metastasis, and therapy resistance. This study shows that non-cancerous human epithelial lung cells can spontaneously shift towards a mesenchymal-like state without genetic changes. This suggests that acquisition of metastasis-associated features may occur prior to genetic alterations and cancerous transformation.

TRANSLATIONAL ONCOLOGY (2023)

Review Chemistry, Multidisciplinary

A review on reactive oxygen species (ROS)-inducing nanoparticles activated by uni- or multi-modal dynamic treatment for oncotherapy

Jinyong Lin, Dong Li, Changhong Li, Ziqi Zhuang, Chengchao Chu, Kostya (Ken) Ostrikov, Erik W. W. Thompson, Gang Liu, Peiyu Wang

Summary: Cancer cells are more susceptible to oxidative stress and nanomaterials-based therapies that generate reactive oxygen species (ROS) have been effective in eliminating cancer cells. These therapies, including chemodynamic therapy, photodynamic therapy, sonodynamic therapy, as well as multi-modal therapies such as combination therapy, have shown significant inhibition of tumor growth. However, the limitations of multi-modal therapy in material preparation and operation protocols hinder its clinical application. Cold atmospheric plasma (CAP), as a reliable source of ROS, light, and electromagnetic fields, provides a simple alternative for implementing multi-modal treatments. Therefore, the emerging field of tumor precision medicine is expected to benefit from these promising multi-modal therapies based on ROS-generating nanomaterials and reactive media like CAPs.

NANOSCALE (2023)

No Data Available